Article
Expression and prognostic assessment of dipeptidyl peptidase IV and related enzymes in B-cell chronic lymphocytic leukemia.
Cancer biology & therapy - 15 Jul 2010
Sulda Melanie L, Abbott Catherine A, Macardle Peter J, Hall Rachel K, Kuss Bryone J
Abstract excerpt
Recent observations of the deregulated expression of several dipeptidyl peptidase (DP) IV-like enzymes in human cancers have led to presumptions of their pathogenic role in cancer. To further explore this concept we have characterized the expression of all DPIV-like enzymes in chronic lymphocytic leukemia (CLL). We have demonstrated the constitutive expression of DPIV, DP8, DP9, DPII and PEP mRNA and DPIV, DP8...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
